South America Respiratory Monitoring Market Trends and Insights
Rising COPD and Asthma Prevalence
Chronic respiratory conditions remain the region’s most persistent health challenge. COPD affects 15.8% of adults over 40 in São Paulo, and 48.4% of diagnosed patients across Argentina, Brazil, and Colombia recorded at least one severe exacerbation during a five-year follow-up, raising hospital readmission rates and costs. Mining-linked pneumoconiosis reaches 42.3% among underground workers in Cundinamarca, Colombia, reinforcing the need for continuous occupational monitoring. South America’s demographic shift toward older age groups, compounded by urban pollution, ensures COPD and asthma remain primary growth engines for the South American respiratory monitoring market.Increasing Adoption of Home-Based Respiratory Monitoring
Telemonitoring first scaled during COVID-19 and has since matured into a standard care pathway. The Brazilian Association of Sleep Medicine formalized tele-PAP guidelines that improved equipment adherence and lowered clinic load.Home sleep tests validated by the ELSA-Brasil cohort showed strong diagnostic concordance, proving that reliable results do not require lab settings. Chile’s chronic respiratory home-care pilots reported higher patient satisfaction and better quality-of-life scores, bolstering payer confidence. With broadband and smartphone penetration climbing, clinicians can now supervise treatment plans remotely, fueling growth in the South American respiratory monitoring market.High Capital Cost of Advanced Devices
State hospitals and rural clinics struggle to fund AI-ready platforms that cost multiples of basic spirometers. Cheaper pulse oximeters often lack clinical validation, while premium sensors remain out of reach for many facilities, delaying technology refresh cycles. Supply-chain constraints and currency volatility add further pressure, tempering immediate penetration rates inside the South American respiratory monitoring market.Other drivers and restraints analyzed in the detailed report include:
- Technological Shift Toward Wearable/Connected Devices
- Expansion of Tele-Pulmonology Reimbursement in South America
- Limited Reimbursement for Diagnostic Procedures
Segment Analysis
Spirometers remain the cornerstone of pulmonary evaluation, accounting for 32.70% of 2025 revenues. Rigorous guidelines from the Latin American Thoracic Association standardize test protocols and secure ongoing purchases for primary and secondary care centers. Peak-flow meters support routine self-management, whereas full polysomnography systems address a growing sleep-disorder workload.Capnographs post the fastest 13.58% CAGR thanks to integrations within multi-parameter monitors that visualize ventilation in real time. Partnerships such as Masimo and Philips expand installed bases in ICUs and surgical suites, reinforcing networked care models. Pulse oximetry continues to spread through home-care packs, while niche research sensors cater to specialized procedures.
Conventional table-top hardware held 34.05% of the South American respiratory monitoring market share in 2025. Hand-held devices add portability for outpatient screening, and wireless adapters streamline data uploads to electronic records. Yet the momentum clearly favors intelligent, cloud-connected systems, which exhibit a 16.02% CAGR. Smart masks and AI-driven ventilator algorithms convert high-frequency data into forecasts of decompensation, allowing timely intervention. Vendors that combine firmware updates, analytics dashboards, and secure cloud storage continue to outpace pure hardware rivals in the South American respiratory monitoring market.
Complete Report Scope:
- By Device Type
- Spirometers
- Peak Flow Meters
- Sleep Test/Polysomnography Devices
- Gas Analyzers
- Pulse Oximeters
- Capnographs
- Other Devices
- By Technology
- Conventional Table-top
- Hand-held
- Wearable / Patch-based
- Wireless-enabled (Bluetooth/Wi-Fi)
- AI-integrated & Cloud-connected
- By End-user
- Hospitals & ICUs
- Ambulatory Surgical & Specialty Clinics
- Sleep Laboratories & Diagnostic Centres
- Home-Care Settings
- Occupational Health & Industrial Sites
- By Application
- COPD
- Asthma
- Sleep Apnea
- Pulmonary Fibrosis & ILD
- Respiratory Infections (incl. COVID-19)
- Others
- By Country
- Brazil
- Argentina
- Rest of South America
List of Companies Covered in this Report:
- Medtronic
- Dragerwerk
- Koninklijke Philips
- Resmed
- GE HealthCare Technologies Inc.
- Nihon Kohden
- Beckton Dickinson
- Hamilton Medical
- Masimo
- Nonin Medical
- Mindray Bio-Medical Electronics Co., Ltd.
- Fisher & Paykel Healthcare
- Smiths Group
- Vyaire Medical
- Hillrom / Baxter International Inc.
- Schiller
- WEINMANN Emergency Medical Technology
- LivaNova
- Aerogen Ltd.
- Nihon Kohden
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Medtronic plc
- Dragerwerk AG & Co. KGaA
- Koninklijke Philips N.V.
- ResMed Inc.
- GE HealthCare Technologies Inc.
- Nihon Kohden Corporation
- Becton, Dickinson and Company
- Hamilton Medical AG
- Masimo Corporation
- Nonin Medical Inc.
- Mindray Bio-Medical Electronics Co., Ltd.
- Fisher & Paykel Healthcare Ltd.
- Smiths Medical (ICU Medical)
- Vyaire Medical Inc.
- Hillrom / Baxter International Inc.
- Schiller AG
- WEINMANN Emergency Medical Technology
- LivaNova PLC
- Aerogen Ltd.
- Nihon Kohden

